American women are silently suffering while the FDA drags its feet on reviewing the abortion drug mifepristone.

Seeking Alpha's roundup of statements, announcements, and remarks that could impact markets, sectors, or individual ...

A new analysis of drug trials used to approve medicines in the United States shows how far modern medicine still has to go to ...

After a major storm blankets Connecticut with more than a foot of snow beginning Sunday, arctic air will create dangerously ...

As snow slams Connecticut, state officials offered tips on how to handle power outages. They addressed everything from ...

The Supreme Court granted certiorari to review whether a generic drugmaker that fully carves out a patented use from its ...

Live Action alleges "reckless distribution" of the abortion drug mifepristone, urging the Trump administration to suspend its ...

SHRC initiates legal action against pharma firm for drug mix-up at Thiruvananthapuram's Regional Cancer Centre, ensuring accountability.

Lice thrive in cold weather, causing weight loss up to 0.21 pounds daily. Systemic drugs work best on sucking lice while topical options handle both types.

Click Therapeutics’ CEO discusses the first FDA-cleared depression app, migraine treatment breakthrough, and digital ...

On January 16, 2026, the U.S. Supreme Court announced its intent to hear the case of Hikma v. Amarin. This case follows the landmark GSK v. Teva ...

After passing on one skinny label case a few years ago, the U.S. Supreme Court agreed to delve into the dark hole the Federal Circuit has dug for drug label carveouts that allow generic drugs and ...